Company intelligence / Profile preview
Athlon Pharmaceuticals
- Ownership
- Private
- Development stage
- Other
Overview
Athlon Pharmaceuticals was a specialty pharmaceutical company based in Fort Worth, Texas, that focused on the development and commercialization of products for respiratory and pain management. The company was best known for its portfolio of prescription products, including the Tussi-Organidin line of cough and cold medications. In 1996, Athlon was acquired by Forest Laboratories for approximately $55 million to strengthen Forest's presence in the specialty respiratory market. Following the acquisition, its operations and product lines were integrated into Forest Laboratories, which was later acquired by Actavis (now AbbVie).
- Therapeutic areas
- NeurologyPulmonology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Athlon Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Athlon Pharmaceuticals.